JAK1 pathway inhibitors for the treatment of gastrointestinal disease
Abstract:
This disclosure relates to JAK1 pathway inhibitors and the use thereof in treating gastrointestinal diseases or disorders such as ulcerative colitis.
Information query
Patent Agency Ranking
0/0